Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR

Zhongxia Wang(Nanjing Drum Tower Hospital), Tao Chen(First Affiliated Hospital of Xi'an Jiaotong University), Junhui Liu(Guangxi University), Tao Zhang(Lu'an First People's Hospital), Zuyi Yuan(First Affiliated Hospital of Xi'an Jiaotong University), Lizhe Sun(First Affiliated Hospital of Xi'an Jiaotong University), Xiaojuan Fan(First Affiliated Hospital of Xi'an Jiaotong University), Yuanyuan Wei(First Affiliated Hospital of Xi'an Jiaotong University), Rui Feng Li(Beijing University of Chinese Medicine)
PPAR Research
January 1, 2016
10.1155/2016/7407153
Cited by 6

Related Papers

Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS
|Metabolomics|2016|368
Normalization and integration of large-scale metabolomics data using support vector regression
|Metabolomics|2016|177
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
|The Lancet|2023|139
Phenol adsorption equilibrium and kinetics on zeolite X/activated carbon composite
|Journal of the Taiwan Institute of Chemical Engineers|2016|126
Association of Blood Pressure Trajectories in Early Life with Subclinical Renal Damage in Middle Age
|Journal of the American Society of Nephrology|2018|102